Study: NCT00111605

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA
Description: A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA
Description: A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA
Description: A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA
Description: A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA
Description: A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA
Description: A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA
Description: A 0.75 mL intramuscular injection of HIV gag DNA vaccine into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA plus IL-12 DNA adjuvant
Description: Injection IL-12 DNA adjuvant intramuscularly into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA plus IL-12 DNA adjuvant
Description: Injection IL-12 DNA adjuvant intramuscularly into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA plus IL-12 DNA adjuvant
Description: Injection IL-12 DNA adjuvant intramuscularly into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-1 gag DNA plus IL-12 DNA adjuvant
Description: Injection IL-12 DNA adjuvant intramuscularly into the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CTL MEP/RC529-SE/GM-CSF (CTL MEP vaccine)
Description: A 1 mL intramuscular injection in the deltoid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sodium chloride injection (0.9%)
Description: All placebo groups will receive an intramuscular injection of sodium chloride (0.9%) in the deltoid.~Group 1 will receive a 0.75 mL injection on Days 0, 28, and 84. Group 2 will receive a 0.8 mL injection on Days 0, 28, and 84. Group 3 will receive a 1.0 mL injection on Days 0, 28, and 84. Group 4 will receive a 1.5 mL injection on Days 0, 28, and 84. Group 5 will receive a 0.75 mL injection on Days 0, 28, 84, 168, and 273. Group 6 will receive a 1.5 mL injection on Days 0, 28, 84, 168, and 273. Group 7 will receive a 1.5 mL injection on Days 0, 28, and 84 and a 1 mL injection into the deltoid on Days 168 and 273.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sodium chloride injection (0.9%)
Description: All placebo groups will receive an intramuscular injection of sodium chloride (0.9%) in the deltoid.~Group 1 will receive a 0.75 mL injection on Days 0, 28, and 84. Group 2 will receive a 0.8 mL injection on Days 0, 28, and 84. Group 3 will receive a 1.0 mL injection on Days 0, 28, and 84. Group 4 will receive a 1.5 mL injection on Days 0, 28, and 84. Group 5 will receive a 0.75 mL injection on Days 0, 28, 84, 168, and 273. Group 6 will receive a 1.5 mL injection on Days 0, 28, 84, 168, and 273. Group 7 will receive a 1.5 mL injection on Days 0, 28, and 84 and a 1 mL injection into the deltoid on Days 168 and 273.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sodium chloride injection (0.9%)
Description: All placebo groups will receive an intramuscular injection of sodium chloride (0.9%) in the deltoid.~Group 1 will receive a 0.75 mL injection on Days 0, 28, and 84. Group 2 will receive a 0.8 mL injection on Days 0, 28, and 84. Group 3 will receive a 1.0 mL injection on Days 0, 28, and 84. Group 4 will receive a 1.5 mL injection on Days 0, 28, and 84. Group 5 will receive a 0.75 mL injection on Days 0, 28, 84, 168, and 273. Group 6 will receive a 1.5 mL injection on Days 0, 28, 84, 168, and 273. Group 7 will receive a 1.5 mL injection on Days 0, 28, and 84 and a 1 mL injection into the deltoid on Days 168 and 273.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sodium chloride injection (0.9%)
Description: All placebo groups will receive an intramuscular injection of sodium chloride (0.9%) in the deltoid.~Group 1 will receive a 0.75 mL injection on Days 0, 28, and 84. Group 2 will receive a 0.8 mL injection on Days 0, 28, and 84. Group 3 will receive a 1.0 mL injection on Days 0, 28, and 84. Group 4 will receive a 1.5 mL injection on Days 0, 28, and 84. Group 5 will receive a 0.75 mL injection on Days 0, 28, 84, 168, and 273. Group 6 will receive a 1.5 mL injection on Days 0, 28, 84, 168, and 273. Group 7 will receive a 1.5 mL injection on Days 0, 28, and 84 and a 1 mL injection into the deltoid on Days 168 and 273.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sodium chloride injection (0.9%)
Description: All placebo groups will receive an intramuscular injection of sodium chloride (0.9%) in the deltoid.~Group 1 will receive a 0.75 mL injection on Days 0, 28, and 84. Group 2 will receive a 0.8 mL injection on Days 0, 28, and 84. Group 3 will receive a 1.0 mL injection on Days 0, 28, and 84. Group 4 will receive a 1.5 mL injection on Days 0, 28, and 84. Group 5 will receive a 0.75 mL injection on Days 0, 28, 84, 168, and 273. Group 6 will receive a 1.5 mL injection on Days 0, 28, 84, 168, and 273. Group 7 will receive a 1.5 mL injection on Days 0, 28, and 84 and a 1 mL injection into the deltoid on Days 168 and 273.